Discover
ARQT
Arcutis Biotherapeutics, Inc.
28.03
1 x 28.02
1 x 28.05
bid
ask
-
0.23
0.81%
12:04 PM
timesize
| Ytd | -3.48% | |
| 1y | 92.65% |
27.69
day range
28.46
13.70
52 week range
31.77
| Open | 28.05 | Prev Close | 28.26 | Low | 27.69 | High | 28.46 | Mkt Cap | 3.53B |
| Vol | 161.86K | Avg Vol | 1.80M | EPS | -0.03 | P/E | -942.00 | Forward P/E | 158.73 |
| Beta | 1.48 | Short Ratio | 7.38 | Inst. Own | 109.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 24.26 | 200-d Avg | 25.02 | 1yr Est | 34.63 |
| Income Statement | |||
| Total Revenue | 105.40M | ||
| Revenues (USD) | 105.40M | ||
| Cost of Revenue | 9.78M | ||
| Gross Profit | 95.61M | ||
| Operating Expenses | 104.70M | ||
| Research and Development Expense | 30.63M | ||
| Selling, General and Administrative Expense | 74.08M | ||
| Operating Income | -9.09M | ||
| Interest Expense | 4.37M | ||
| Income Tax Expense | 93.00K | ||
| Net Income | -11.29M | ||
| Net Income Common Stock | -11.29M | ||
| Net Income Common Stock (USD) | -11.29M | ||
| Consolidated Income | -11.29M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -6.83M | ||
| Earning Before Interest & Taxes (USD) | -6.83M | ||
| Weighted Average Shares | 129.37M | ||
| Weighted Average Shares Diluted | 129.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 35.07M | ||
| Cash and Equivalents (USD) | 35.07M | ||
| Investments | 189.24M | ||
| Investments Current | 189.24M | ||
| Trade and Non-Trade Receivables | 144.38M | ||
| Current Assets | 438.06M | ||
| Property, Plant & Equipment Net | 5.40M | ||
| Total Assets | 460.00M | ||
| Debt Current | 7.95M | ||
| Total Debt | 114.67M | ||
| Current Liabilities | 163.20M | ||
| Debt Non-Current | 106.72M | ||
| Total Liabilities | 270.36M | ||
| Accumulated Retained Earnings (Deficit) | -1.15B | ||
| Accumulated Other Comprehensive Income | -514.00K | ||
| Shareholders Equity | 189.65M | ||
| Shareholders Equity (USD) | 189.65M | ||
| Assets Non-Current | 21.95M | ||
| Total Debt (USD) | 114.67M | ||
| Goodwill and Intangible Assets | 14.25M | ||
| Inventory | 37.39M | ||
| Liabilities Non-Current | 107.15M | ||
| Trade and Non-Trade Payables | 18.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 562.00K | ||
| Net Cash Flow from Financing | 1.07M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.14M | ||
| Issuance (Purchase) of Equity Shares | 1.07M | ||
| Net Cash Flow from Investing | -11.33M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -11.33M | ||
| Net Cash Flow from Operations | 2.24M | ||
| Effect of Exchange Rate Changes on Cash | -119.00K | ||
| Share Based Compensation | 10.69M | ||